182 related articles for article (PubMed ID: 2980513)
1. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S
Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513
[TBL] [Abstract][Full Text] [Related]
2. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
3. Glucose consumption in recurrent gliomas.
Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
[TBL] [Abstract][Full Text] [Related]
4. Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography.
Sasaki H; Kanno I; Murakami M; Shishido F; Uemura K
J Cereb Blood Flow Metab; 1986 Aug; 6(4):447-54. PubMed ID: 3488323
[TBL] [Abstract][Full Text] [Related]
5. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
[TBL] [Abstract][Full Text] [Related]
6. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
[TBL] [Abstract][Full Text] [Related]
7. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062
[TBL] [Abstract][Full Text] [Related]
9. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
10. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
11. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
13. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
[TBL] [Abstract][Full Text] [Related]
14. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].
Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M
Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854
[No Abstract] [Full Text] [Related]
15. Effects of hyperglycemia on FDG uptake in human brain and glioma.
Ishizu K; Nishizawa S; Yonekura Y; Sadato N; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Miyatake S; Ishikawa M
J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665
[TBL] [Abstract][Full Text] [Related]
16. [Tomographic mapping of rate constants of [F-18] FDG model].
Sasaki H; Kanno I; Miura S; Murakami M; Takahashi K; Shishido F; Uemura K
Kaku Igaku; 1985 Jan; 22(1):81-4. PubMed ID: 3873558
[No Abstract] [Full Text] [Related]
17. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
19. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of brain tumors.
Rozental JM
Neurol Clin; 1991 May; 9(2):287-305. PubMed ID: 1944100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
